-- Appointment also further strengthens growing Pharmacovigilance practice
KAISERSLAUTERN, Germany, April 15, 2013 /PRNewswire/ -- pharma solutions international GmbH (pharmaSOL) announced today the appointment of Dr. Marc A. Zittartz to the position of Chief Strategy Officer, starting June 1st, 2013. In this role, he will be responsible for developing and implementing pharmaSOL's strategy to deliver innovative technology solutions, GxP compliant cloud hosting and expert consulting services for the life sciences industry. He also becomes a part of the executive management team.
"With his rich experience in implementing pharmacovigilance processes and best practices in IT systems, Dr. Zittartz strengthens the existing PV practice at pharmaSOL and continues the investment that pharmaSOL has made in this area," said Torsten Adam, pharmaSOL's CEO and Managing Director. "This follows the recent development of the cloud application, psiXchange, to enable centralized safety reporting to investigators and ethics committees in clinical trials".
Dr. Zittartz has more than 10 years of experience working in the pharmaceutical industry in both Europe and North America. In his previous roles he successfully managed all aspects of GxP relevant IT systems for Regulatory Affairs, Clinical Development and Pharmacovigilance. Dr. Zittartz holds a Ph.D. in physics from the University of Cologne, Germany. Throughout his career he has been a consistent contributor to the advancement of R&D IT solutions through several networks such as the Oracle Health Sciences User Group, DIA and pvtech.
pharmaSOL is a leading provider of innovative technology solutions – including GxP compliant hosting and outsourcing – and expert consulting services for the life sciences industry with offices in Germany, the U.K., and the United States. Providing high quality capabilities to our pharmaceutical, biotechnology, CROs and regulatory partners for over 13 years, we are committed to delivering efficient and practical end-to-end solutions that allow our clients to focus more successfully on their core business needs. Website: www.pharmasol.de. Twitter: @pharmasol